A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

Clinical trial NCT04752332 · TERMINATED

Trial details

NCT number: NCT04752332
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2021-05-10
Primary completion: 2024-06-26
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.